These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1425774)

  • 1. Immunolocalization of secretogranin II, chromogranin A, and chromogranin B in differentiating human neuroblastoma cells.
    Giudici AM; Sher E; Pelagi M; Clementi F; Zanini A
    Eur J Cell Biol; 1992 Aug; 58(2):383-9. PubMed ID: 1425774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of the neuroendocrine cerebellum: expression of secretogranin II, chromogranin A and chromogranin B in mouse cerebellar unipolar brush cells.
    Nunzi MG; Mugnaini E
    Neuroscience; 2009 Sep; 162(3):673-87. PubMed ID: 19217926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
    Thompson ME; Valentine DL; Strada SJ; Wagner JA; Scammell JG
    Mol Pharmacol; 1994 Nov; 46(5):880-9. PubMed ID: 7969075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromogranin A, chromogranin B and secretogranin II mRNAs in the pituitary and adrenal glands of various mammals. Regulation of chromogranin A, chromogranin B and secretogranin II mRNA levels by estrogen.
    Lloyd RV; Hawkins K; Jin L; Kulig E; Fields K
    Lab Invest; 1992 Sep; 67(3):394-404. PubMed ID: 1405495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of secretogranin II and insulin in a nerve growth factor-differentiated insulinoma cell line.
    Sher E; Rosa P; Bassetti M; Zanini A
    Eur J Cell Biol; 1995 May; 67(1):15-22. PubMed ID: 7641727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.
    Pagani A; Fischer-Colbrie R; Sanfilippo B; Winkler H; Cerrato M; Bussolati G
    Diagn Mol Pathol; 1992 Sep; 1(3):165-72. PubMed ID: 1342962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretogranin III in human neuroendocrine tumours: a comparative immunohistochemical study with chromogranins A and B and secretogranin II.
    Portela-Gomes GM; Grimelius L; Stridsberg M
    Regul Pept; 2010 Nov; 165(1):30-5. PubMed ID: 20550951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranins A and B and secretogranin II as prohormones for regulatory peptides from the diffuse neuroendocrine system.
    Helle KB
    Results Probl Cell Differ; 2010; 50():21-44. PubMed ID: 20217490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of chromogranins and regulation of their synthesis and processing in a neuroendocrine prostate tumor cell line.
    Ischia R; Culig Z; Eder U; Bartsch G; Winkler H; Fischer-Colbrie R; Klocker H
    Prostate Suppl; 1998; 8():80-7. PubMed ID: 9690667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression and processing of chromogranin A and secretogranin II in relation to the secretory status of endocrine cells.
    Peinado JR; Vazquez-Martinez R; Cruz-García D; Ruiz-Navarro A; Anouar Y; Tonon MC; Vaudry H; Gracia-Navarro F; Castano JP; Malagón MM
    Endocrinology; 2006 Mar; 147(3):1408-18. PubMed ID: 16357044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
    Gazdar AF; Helman LJ; Israel MA; Russell EK; Linnoila RI; Mulshine JL; Schuller HM; Park JG
    Cancer Res; 1988 Jul; 48(14):4078-82. PubMed ID: 3383200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
    Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
    Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivities for chromogranin A and B, and secretogranin II in the guinea pig entero-endocrine system: cellular distributions and intercellular heterogeneities.
    Cetin Y; Grube D
    Cell Tissue Res; 1991 May; 264(2):231-41. PubMed ID: 1878943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells.
    Weiss C; Winkler H; Laslop A
    Neurochem Int; 2001 Jan; 38(1):43-52. PubMed ID: 10913687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
    Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
    J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretogranin II: a key AP-1-regulated protein that mediates neuronal differentiation and protection from nitric oxide-induced apoptosis of neuroblastoma cells.
    Li L; Hung AC; Porter AG
    Cell Death Differ; 2008 May; 15(5):879-88. PubMed ID: 18239671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of secretogranin II and high-capacity, low-affinity Ca2+ storage role in nucleoplasmic Ca2+ store vesicles.
    Yoo SH; Chu SY; Kim KD; Huh YH
    Biochemistry; 2007 Dec; 46(50):14663-71. PubMed ID: 18020452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen and dexamethasone on a transgenic pituitary cell line. Regulation of hormone and chromogranin/secretogranin expression.
    Thiny MT; Antczak C; Fields K; Jin L; Lloyd RV
    Lab Invest; 1994 Jun; 70(6):899-906. PubMed ID: 7912292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretogranin II in extra-adrenal paragangliomas.
    Schmid KW; Schröder S; Dockhorn-Dworniczak B; Kirchmair R; Tötsch M; Böcker W; Fischer-Colbrie R
    Mod Pathol; 1994 Apr; 7(3):347-53. PubMed ID: 8058707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin and secretogranin-II, a marker for the regulated pathway, are secreted in parallel by pituitary GH4C1 cells.
    Hinkle PM; Scammell JG; Shanshala ED
    Endocrinology; 1992 Jun; 130(6):3503-11. PubMed ID: 1597152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.